📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ADARx Pharmaceuticals

1.1 - Company Overview

ADARx Pharmaceuticals Logo

ADARx Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of genetic medicine technologies focused on the base editing of mRNA transcripts.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ADARx Pharmaceuticals

Omniome Logo

Omniome

HQ: United States Website
  • Description: Provider of a proprietary DNA sequencing platform delivering high-accuracy short-read sequencing using Sequencing by Binding (SBB) chemistry. Offers the Onso hardware and software system; validated exome/panel sequencing; single-cell RNA-Seq solutions; and tools for cancer research and gene editing, with lower error rates than traditional sequencing by synthesis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Omniome company profile →
Molecular Assemblies Logo

Molecular Assemblies

HQ: United States Website
  • Description: Provider of proprietary Fully Enzymatic Synthesis (FES) technology to produce long, pure, accurate DNA up to 400 nucleotides without post-synthesis purification; custom DNA oligos for CRISPR, cloning and NGS; gene editing, protein engineering and gene assembly services; and a partnering program licensing FES for on-site synthesis with an automated platform, proprietary reagents and research-use licenses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Molecular Assemblies company profile →
Interactive Biosoftware Logo

Interactive Biosoftware

HQ: France Website
  • Description: Provider of software solutions for clinical and research scientists in the human genetics field, focusing on practical software applications for health care and life sciences, particularly molecular biology, serving geneticists and researchers worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Interactive Biosoftware company profile →
DNA Script Logo

DNA Script

HQ: France Website
  • Description: Provider of enzymatic DNA synthesis solutions, featuring the SYNTAX benchtop DNA printer for on-demand custom oligo production up to 120 nucleotides using Enzymatic DNA Synthesis (EDS). Offers SYNTAX 96 Hi-Fidelity and 96 Standard kits for 96 oligos (up to 120 nt or 80 nt), the SYNTAX 192 Label Kit for probes with up to two labels for qPCR and FISH, and SYNTAX Labels including fluorophores, quenchers, and biotin.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DNA Script company profile →
Bluebee Logo

Bluebee

HQ: The Netherlands Website
  • Description: Provider of a secure global, cloud-based accelerated bio-informatics/genomics platform and high-performance genomics solutions to process, analyze, share and store large volumes of genomics data, enabling research and clinical labs to reduce cost and time-to-diagnose.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bluebee company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ADARx Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ADARx Pharmaceuticals

2.2 - Growth funds investing in similar companies to ADARx Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ADARx Pharmaceuticals

4.2 - Public trading comparable groups for ADARx Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ADARx Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ADARx Pharmaceuticals

What does ADARx Pharmaceuticals do?

ADARx Pharmaceuticals is a provider of genetic medicine technologies focused on the base editing of mRNA transcripts.

Who are ADARx Pharmaceuticals's competitors?

ADARx Pharmaceuticals's competitors and similar companies include Omniome, Molecular Assemblies, Interactive Biosoftware, DNA Script, and Bluebee.

Where is ADARx Pharmaceuticals headquartered?

ADARx Pharmaceuticals is headquartered in United States.

How many employees does ADARx Pharmaceuticals have?

ADARx Pharmaceuticals has 1,000 employees 🔒.

When was ADARx Pharmaceuticals founded?

ADARx Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is ADARx Pharmaceuticals in?

ADARx Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ADARx Pharmaceuticals

Who are the top strategic acquirers in ADARx Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in ADARx Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ADARx Pharmaceuticals?

Top strategic M&A buyers groups and sectors for ADARx Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ADARx Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in ADARx Pharmaceuticals's sector and industry vertical?

Top PE firms investing in ADARx Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ADARx Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ADARx Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ADARx Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ADARx Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ADARx Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ADARx Pharmaceuticals?

The key public trading comparables and valuation benchmarks for ADARx Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ADARx Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ADARx Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ADARx Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ADARx Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ADARx Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in ADARx Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ADARx Pharmaceuticals